Biopharmaceuticals commonly called “biologics,” include a wide variety of products derived from human, animal, or microbial sources with the help of biotechnology. A surge of bio-APIs and their growing penetration into multiple therapies create an attractive market for pharmaceutical chemical suppliers.Continue reading
A surging number of biologic APIs and their growing penetration into multiple therapies create an attractive market segment for pharmaceutical ingredient suppliers but not one without challenges, analyzes Kline’s recently published Biologics: Market Opportunities for Chemicals Suppliers. To learn about key findings from the study, REGISTER for a complimentary webinar, taking place on October 17, 2019.
Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market. Some established biologics, such as Humira and Avastin, maintained their growth of the last decade in 2018, with sales growing by 8.2% and 9.5%, respectively. New drugs such as Opdivo, which was first introduced in 2017, witnessed particularly robust growth in the overall biopharmaceutical market.Continue reading
While HI&I cleaning and personal care applications are relatively well-defined, mapped, and known markets, industrial applications are more complex and fragmented. A variety of industrial applications in which surfactants may not be a focus for surfactant suppliers is causing a lower degree of rivalry. The market itself is very fragmented with few larger applications, such as food, crop protection, and lubricants, and many mid-sized and smaller applications. Different end-use applications have various expectations from consumers and unmapped driving forces. Kline’s in-progress report will assist industrial surfactants suppliers by providing them with a clear picture of the market.Continue reading
In June, hundreds of participants in the wipes market convened for the INDA (Association of the Nonwoven Fabrics Industry) World of Wipes annual meeting in Atlanta, Georgia. There were many presentations from speakers representing industry associations, chemical suppliers, wipes manufacturers, and raw material suppliers. A common theme that was raised pertains to increasing efforts to limit single-use plastic and the plastic-free movement. Many U.S. states and countries, especially in Europe, are phasing out single-use plastics, and by 2021 in Europe, wipes packages will need to contain labeling that shows they “contain plastics” if they do. Since wipes contain plastic components and packaging, the industry needs to keep a watchful eye on this trend.Continue reading
The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading
Global synthetic latex polymers manufacturing capacity is around 32.2 million wet tonnes, and global consumption is estimated at 25.2 million wet tonnes in 2017. Hence, a utilization of nearly 78% is estimated in the global synthetic latex industry.Continue reading
The market of synthetic latex polymers assumes a unique set of characteristics in every geography, from performance of the economy, purchasing power of the population, and industrialization to demand patterns, competition from alternate technologies, and performance of the polymers in specific end uses.
North America and China both represent the largest markets of synthetic latex polymers by volume, each accounting for an approximate 25% share of global consumption. Meanwhile, India, which has a much smaller share of around 5% of global consumption, is the fastest-growing market for synthetic latex polymers in the world. It is these three key geographical markets of North America, China, and India that Kline studies in depth this year in its continuous Synthetic Latex Polymers Global Series: Business Analysis and Opportunities program.Continue reading
This interview was originally published in Expression Cosmétique Guide des Ingrédients Cosmétiques 2018, p.28-30, www.editionsbgm.fr
The cosmetics industry and its upstream players are moving on with their transformation. Nikola Matic, Head of the Chemicals & Materials Department for Kline & Company, shares with us the main changes in the industry and the future trends.
Can you give us an update on the sales of ingredients in 2017?Continue reading
By definition, excipients are inactive substances that serve as a medium or vehicle for pharmaceutical active drug substances. Over the years, excipients have been increasingly developed to provide important functionalities to pharmaceutical formulations. The global pharmaceutical market is worth more than USD 1.1 trillion as of 2017 and expected to grow more than 4% annually over the next five years. The global market of specialty excipients in the overall pharmaceutical industry is estimated at about USD 6.8 billion in 2017.Continue reading
Accounting for around 7.5% of the global market share, Southeast Asia is the fourth largest consumer of synthetic latex polymers globally, according to Southeast Asia report from Kline’s continuous program Synthetic Latex Polymers: Global Business Analysis and Opportunities. A robust economic growth, low industry regulations, and stability in raw material prices appeal to multinational corporations and domestic suppliers, increasing the market rivalry in the region.Continue reading